Serum and salivary microRNA biomarkers reveal oxidative stress dysregulation in coronary artery disease, suggesting new non-invasive detection methods.
The consistent downregulation of miR-127-3p in plasma and saliva highlights its potential as a clinically relevant, non-invasive biomarker, supporting early detection and monitoring strategies for CAD through accessible body fluids.
No takes yet. Share an insight, caveat, or question.
Arthisri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: